We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information about how the Competition and Markets Authority responded to the coronavirus (COVID-19) outbreak.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
This collection brings together all the Competition and Markets Authority's (CMA) board meeting minutes.
Information about what to do if you receive a warning or advisory letter from the CMA.
Tell the CMA about issues with a business, a market, or to provide information about a new or existing case.
Letters sent by the Competition and Markets Authority (CMA) to companies about their non-compliance with market investigation orders and undertakings.
All data on CMA spending over £500 with an electronic purchasing card solution (ePCS) since March 2015.
All data on external disclosures made to the CMA
Tell the CMA about competition and consumer issues.
Documents relating to workforce management information summary data for the Competition and Markets Authority.
This collection brings together all documents about our spend on non-consolidated performance related pay.
The Competition and Markets Authority (CMA) has a statutory duty to comply with the Public Records Act 1958 (PRA).
The investigation will consider whether Vifor Pharma has been engaging in anti-competitive conduct.
The CMA has today published its main concerns following an initial review into the veterinary sector.
Following a provisional clearance in February, the CMA is now allowing the proposed deal between Arçelik and Whirlpool to go ahead.
After extensive engagement, the CMA has published its Annual Plan for 2024 to 2025.
The CMA has today appointed its new General Counsel and Executive Director for Digital Markets.
Promoting competitive markets and tackling unfair behaviour.
The CMA believes the CAT’s decision to overturn nearly £100 million of fines for drug firms despite initially confirming flagrant anti-competitive conduct is fundamentally misconceived. The CMA has a duty to ensure effective competition law enforcement and will be seeking...
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.